A Study of LAD106 in Healthy Adult Participants

NCT07471932 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: LAD106
DRUG: Lebrikizumab
OTHER: Placebo

Sponsor

Almirall, S.A.